AstraZeneca-Amgen Tezspire gets USFDA nod for chronic rhinosinusitis with nasal polyps
- 18 October 2025
- 5 days ago
AstraZeneca-Amgen Tezspire recommended for approval in EU for chronic rhinosinusitis with nasal polyps
- 22 September 2025
- 1 month ago
Recent News
Early life sugar restriction linked to lasting hea...
- 23 October, 2025
Air Pollution May Slow Infant Brain Development: S...
- 23 October, 2025
AI Outperforms Traditional Tools in Predicting Hea...
- 23 October, 2025
Nearly Half of Acute Pancreatitis Patients Develop...
- 23 October, 2025
Can Fat You Can’t See Put You at Risk for Stroke a...
- 23 October, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.